NCT06432803View on ClinicalTrials.gov

Metabolic Imaging for Diagnosis and Prognostication of Autoimmune encephalitiS

Active, not recruitingOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

December 31, 2024

Conditions
Paraneoplastic Neurological SyndromeAutoimmune Encephalitis
Interventions
OTHER

PET-Scan analysis

Investigate and determine the clinical value of different cortex/striatal metabolic ratio patterns in each antibody-specific subtype of autoimmune encephalitis

Trial Locations (1)

69495

CHU Lyon, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT06432803 - Metabolic Imaging for Diagnosis and Prognostication of Autoimmune encephalitiS | Biotech Hunter | Biotech Hunter